Use of antioxidant supplements during breast cancer treatment : A comprehensive review
Transforming growth factor-β signaling : Emerging stem cell target in metastatic breast cancer?
Acupuncture for treating hot flashes in breast cancer patients : A systematic review
Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo)
Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients
Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population
Calmodulin modulates Akt activity in human breast cancer cell lines
Columnar cell lesions, mammographic density and breast cancer risk
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients : A double-blind, randomized cross-over study
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer : An option for monitoring response to breast cancer related therapies
Weekly epirubicin in the treatment of gestational breast cancer (GBC)
Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearchTM BLN Assay in the operating room : Results of the Cardiff study
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk
DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus
Vitamin D receptor variants and breast cancer risk in the Polish population
Autoimmune hypothyroidism and breast cancer in the elderly
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy
Cyclin E deregulation is an early event in the development of breast cancer
Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months